Session Details
[1-P]Poster
Mon. Mar 16, 2026 1:00 PM - 2:00 PM JST
Mon. Mar 16, 2026 4:00 AM - 5:00 AM UTC
Mon. Mar 16, 2026 4:00 AM - 5:00 AM UTC
ポスター会場4(B105)
[1-P-026]Evaluation Using a Sodium Valproate-Induced Autism Spectrum Disorder (ASD) model
*Masana Kamioka1, Yoshiyuki Hayashida1, Takashi Tashiro1, Kousuke Morizumi1, Katsuhide Nishi1, Naoyuki Hironaka1 (1. Research Unit Ⅰ Drug Discovery Innovation Center Mediford Corporation)
[1-P-027]Elucidation of Behavioral Phenotypes and Neural Functional Alterations in a Chromosome 3
Syndrome Mouse Model
*Shibuki Kenshin1 (1. Tokyo University of Science)
[1-P-028]Evaluation of the Efficacy in a Propionic Acid-Induced Autism Rat Model
*Hiroyasu Murasawa1, Hiroyuki Kobayashi1, Yuya Asano1, Natsuko Yoshida1, Shoko Otsu1, Yuri Noda1, Katsuhiro Higuchi1, Yasushi Hirasawa1, Takahiko Nagase1 (1. Nihon Bioresearch Inc.)
[1-P-029]Involvement of dopamine D2 receptor short form dysfunction in the pathophysiology of schizophrenia
*Hisayoshi Kubota Kubota1, Xinjian Zhang1, Yu Wen1, Masoumeh Khalili1, Xinzhu Zhou1, Akira Sobue1, Taku Nagai1 (1. Division of Behavioral Neuropharmacology, International Center for Brain Science (ICBS), Fujita Health University)
[1-P-030]Modulatory effects of neuropeptide Y (NPY) and peptide YY (PYY) on excitatory synaptic transmission in the rat nucleus tractus solitarius.
*Yoshiaki Ohi1, Kodama Daisuke1 (1. Aichi Gakuin University, School of pharmacy, Laboratory of Neuropharmacology)
[1-P-031]N-ethylmaleimide-sensitive factor was one of candidates targeted for 15-deoxy -Δ12,14-prostaglandin J2
*Tatsurou Yagami1, Yasuhiro Yamamoto1, Hiromi Koma1 (1. Himeji Dokkyo University)
[1-P-032]Region-Specific Phosphorylation Network Analysis in the Mouse Brain
*Satoshi Muraoka1, Naotoshi IWAHARA2, Mayumi Ishida1, Narumi Ikemoto1, Narimi Takaai1, Shin Hisahara 2, Jun Adachi1,3 (1. National Institutes of Biomedical Innovation, Health and Nutrition, 2. Sapporo Medical University, 3. Kyoto University)
[1-P-033]Characterization of water diffusion in brain tissues by SRS microscopy
*Wakana Ozaki1, Ayano Suzuki1,2, Masato Yasui1, Mutsuo Nuriya1,2 (1. Keio University Graduate School of Medicine, 2. Yokohama National University Graduate School of Environment and Information Sciences)
[1-P-034]Prediction of toxicity and mechanism of action using MEA measurements of human iPSC-derived neurons
*Yuto Ishibashi1, Nami Nagafuku1, Ikuro Suzuki1 (1. Tohoku Institute of Technology)
[1-P-035]Neural Activity Mapping in Brain Organoids and Midbrain-Striatum Assembloids Using Ultra-High-Density CMOS-MEA
*Remi Yokoi1, Yuto Ishibashi1, Naoki Matsuda1, Ikuro Suzuki1 (1. Tohoku Institute of Technology)
[1-P-036]Sonic hedgehog signaling pathway alleviates neuroinflammation following traumatic brain injury in mice
*Shotaro Michinaga1, Yasuhiro Ogawa1, Hishinuma Shigeru1 (1. Meiji Pharmaceutical University)
[1-P-037]Centrally administered PGE2 suppresses the micturition reflex via brain EP1/EP2 receptors in rats
*Takahiro Shimizu1, Nobutaka Shimizu2, Shun Tsubouchi1, Mio Togo1, Youichirou Higashi1, Motoaki Saito1 (1. Department of Pharmacology, Kochi Medical School, Kochi University, 2. Pelvic Floor Center, Kochi Medical School, Kochi University)
[1-P-038]Route-Dependent Central Effects and Efficacy Prediction of a Nucleic Acid Drug: Comparison of ICV and IT Administration
*Misae Takakuwa1, Yumi Tomihara1, Kazuya Kawasaki1, Tomoki Shimada1, Keiko Matsune1, Yumi Sakai1, Koji Murakami1 (1. Axcelead Drug Discovery Partners)
[1-P-039]Changes in Gamma-enolase during the Critical Period of the Mouse Visual Cortex
*Hirotaka Oikawa1, Akari Suzuki1, Takahiko Fujikawa1 (1. Suzuka University of Medical Science)
[1-P-040]Comparative neuroanatomical analysis of monoamine distribution in the brain across species using imaging mass spectrometry
*Hiroyuki Neyama1, Ryoma Kizu1, Takahiro Kondo2, Yuki Sugiura1 (1. Kyoto Universtiy, 2. Keio University)
[1-P-041]Effects of JAK inhibitors on postoperative cognitive dysfunction
*Daisuke Kodama1, Yoshiaki Ohi1 (1. Aichi-Gakuin Univ.)
[1-P-042]PRETREATMENT WITH SILVER NANOPARTICLES (“Pikasshu” AgNPs) SELECTIVELY SUPPRESS METHAMPHETAMINE-INDUCED HYPERLOCOMOTION IN MICE
*Junichi Kitanaka1, Nobue Kitanaka2, Kazuo Tomita3, Kento Igarashi3, Moe Matsuo1, Akiko Miyoshi1, Erina Miyoshi1, Nagisa Murakami1, Shosei Takahashi4, Takafumi Miyazaki4, Yoshiaki Kamikawa3, Tomoaki Sato3 (1. Lab. Drug Addict. & Exp. Ther., Sch. Pharm., Hyogo Med. Univ., 2. Dept. Pharmacol., Sch. Med., Hyogo Med. Univ., 3. Dept. Applied Pharmacol., Grad. Sch. Med. & Dent. Sci., Kagoshima Univ., 4. Pikasshu Co., Ltd.)
[1-P-043]Effect of pictilisib, a PI3K inhibitor, on Straub`s tail reaction and analgesia induced by a single administration with morphine in mice
*Akiko Miyoshi1, Nobue Kitanaka2, Moe Matsuo1, Erina Miyoshi1, Nagisa Murakami1, Rika Haramaki1, Yuki Ueda1, Hitomi Yamamoto1, Takahiro Hamana1, Masahiro Nakai1, Kazuo Tomita3, Kento Igarashi3, Tomoaki Sato3, Junichi Kitanaka1 (1. Lab. Drug Addict. & Exp. Ther., Sch. Pharm., Hyogo Med. Univ., 2. Dept. Pharmacol., Sch. Med., Hyogo Med. Univ., 3. Dept. Applied Pharmacol., Grad. Sch. Med. & Dent. Sci., Kagoshima Univ.)
[1-P-044]Effects of Dai-bofu-to on abnormal behaviors induced by a single administration with psychedelic substance DOI in mice
*Erina Miyoshi1, Nobue Kitanaka2, Moe Matsuo1, Akiko Miyoshi1, Nagisa Murakami1, Rika Haramaki1, Yuki Ueda1, Hitomi Yamamoto1, Sho Yuze1, Kazuo Tomita3, Kento Igarashi3, Tomoaki Sato3, Junichi Kitanaka1 (1. Lab. Drug Addict. & Exp. Ther., Sch. Pharm., Hyogo Med. Univ., 2. Dept. Pharmacol., Sch. Med., Hyogo Med. Univ., 3. Dept. Applied Pharmacol., Grad. Sch. Med. & Dent. Sci., Kagoshima Univ.)
[1-P-045]LB-100, A PROTEIN PHOSPHATASE 2A INHIBITOR, ATTENUATES METHAMPHETAMINE-INDUCED STEREOTYPED BEHAVIOR IN MICE
*MOE MATSUO1, Nobue Kitanaka2, Akiko Miyoshi1, Erina Miyoshi1, Nagisa Murakami1, Rika Haramaki1, Yuki Ueda1, Hitomi Yamamoto1, Kentaro Matsuda1, Chisa Kobayashi1, Kazuo Tomita3, Kento Igarashi3, Tomoaki Sato3, Shuhei Nakao1, Junichi Kitanaka1 (1. Lab. Drug Addict. & Exp. Ther., Sch. Pharm., Hyogo Med. Univ., 2. Dept. Pharmacol., Sch. Med., Hyogo Med. Univ., 3. Dept. Applied Pharmacol., Grad. Sch. Med. & Dent. Sci., Kagoshima Univ.)
[1-P-046]CHARACTERISTICS OF ABNORMAL BEHAVIOURS INDUCED BY A HALLUCINOGEN DEXTROMETHORPHAN IN MICE
*Nagisa Murakami1, Nobue Kitanaka2, Moe Matsuo1, Akiko Miyoshi1, Erina Miyoshi1, Yuki Ueda1, Rika Haramaki1, Hitomi Yamamoto1, Kazuo Tomita3, Kento Igarashi3, Tomoaki Sato3, Junichi Kitanaka1 (1. Lab. Drug Addict. & Exp. Ther., Sch. Pharm., Hyogo Med. Univ., 2. Dept. Pharmacol., Sch. Med., Hyogo Med. Univ., 3. Dept. Applied Pharmacol., Grad. Sch. Med. & Dent. Sci., Kagoshima Univ.)
[1-P-047]Mice repeatedly administered with the hallucinogen DOI exhibit a strong tendency to prone position but not locomotor activity as a putative withdrawal symptom
*Nobue Kitanaka1, Moe Matsuo2, Akiko Miyoshi2, Erina Miyoshi2, Nagisa Murakami2, Yuki Ueda2, Rika Haramaki2, Hitomi Yamamoto2, Kazuo Tomita3, Kento Igarashi3, Tomoaki Sato3, Junichi Kitanaka2 (1. Dept. Pharmacol., Sch. Med., Hyogo Med. Univ., 2. Lab. Drug Addict. Exp. Ther., Sch. Pharm., Hyogo Med. Univ., Kobe, Hyogo, Japan, 3. Dept. Applied Pharmacol., Grad. Sch. Med. & Dent. Sci., Kagoshima Univ.)
[1-P-048]Brain region involved in exacerbation of itch-related scratching in atopic dermatitis mice
*Masanori Fujii1, Masahiro Adachi2, Seita Nobuta2 (1. Meijo Univ., 2. Kyoto Pharm. Univ.)
[1-P-049]Aromatic-turmerone analogs improve the phenotype of spinocerebellar ataxia model Purkinje cells
*KENSUKE MOTOMURA1, Boateng Alex2, Masaharu Sugiura2, Ayumu Konno3, Hirokazu Hirai3, Natsuko Hitora1, Yuki Kurauchi1, Hiroshi Katsuki1, Takahiro Seki1,4 (1. Dept Chemico-Pharmacol Sci, Grad Sch Pharm Sci, Kumamoto Univ , 2. Grad. Sch. Pharm. Sci, Sojo Univ , 3. Dept Neurophysiol Neural Repair, Gunma Univ Grad Sch Med , 4. Dept Pharmacol, Fac Pharm Sci, Himeji Dokkyo Univ)